首页 | 本学科首页   官方微博 | 高级检索  
     

复方丁香开胃贴治疗儿童功能性腹痛脾胃虚寒证上市后再评价
引用本文:郭恒昌,胡思源,李新民,白晓红,韩子明,徐辉甫,李学明,梁彩桃,蔡建新,赖维阳,潘树强,刘平定,温凤,马立吉,蔡秋晗,伍戈. 复方丁香开胃贴治疗儿童功能性腹痛脾胃虚寒证上市后再评价[J]. 现代药物与临床, 2018, 41(12): 2166-2170
作者姓名:郭恒昌  胡思源  李新民  白晓红  韩子明  徐辉甫  李学明  梁彩桃  蔡建新  赖维阳  潘树强  刘平定  温凤  马立吉  蔡秋晗  伍戈
作者单位:天津中医药大学第一附属医院, 天津 300193,天津中医药大学第一附属医院, 天津 300193,天津中医药大学第一附属医院, 天津 300193,辽宁中医药大学附属医院, 辽宁 沈阳 110032,新乡医学院第一附属医院, 河南 新乡 453100,武汉市中西医结合医院, 湖北 武汉 430022,邯郸市中医院, 河北 邯郸 056000,潞安矿业(集团)有限责任公司总医院, 山西 长治 046204,武汉市中医医院, 湖北 武汉 430014,河北工程大学附属医院, 河北 邯郸 056002,钦州市妇幼保健院, 广西 钦州 535000,渭南市妇幼保健院, 陕西 渭南 714000,长春市儿童医院, 吉林 长春 130061,淄博市中心医院, 山东 淄博 255000,天津中医药大学第一附属医院, 天津 300193,天津中医药大学第一附属医院, 天津 300193
摘    要:目的 评价复方丁香开胃贴治疗儿童功能性腹痛脾胃虚寒证的有效性及安全性。方法 采用随机双盲、安慰剂平行对照、多中心的方法。计划纳入240例患儿,按照1:1的比例随机分为试验组和对照组。两组分别外用复方丁香开胃贴、模拟贴,疗程2周。结果 共纳入239例患儿,230例进入全分析数据(FAS)集,217例进入符合方案数据(PPS)集,238例进入安全数据(SS)集。两组治疗第2周的腹痛发作天数平均值分别为1.600、2.026,经协方差分析,差异有统计学意义(P=0.0070),且试验组优于对照组。两组腹痛程度的改善率分别为80.00%、67.83%,中医证候有效率分别为86.09%、59.13%,组间比较,差异均有统计学意义(P=0.0355、0.0001),试验组也优于对照组的。试验组发现不良事件9例(7.63%),对照组10例(8.33%);判断为不良反应者,试验组4例(3.39%),对照组3例(2.50%),均表现为皮肤刺激症状。不良事件、不良反应的组间比较,差异均无统计学意义。结论 复方丁香开胃贴治疗儿童功能性腹痛脾胃虚寒证,可以减少腹痛发作天数,改善腹痛程度及中医证候,且安全性好。

关 键 词:复方丁香开胃贴  儿童  功能性腹痛  脾胃虚寒证  上市后临床再评价
收稿时间:2018-10-28

Post-marketing revaluation of Compound Dingxiang Kaiwei Paste in treatment of functional abdominal pain with deficient cold of spleen and stomach syndrome in children
GUO Hengchang,HU Siyuan,LI Xinmin,BAI Xiaohong,HAN Ziming,XU Huifu,LI Xueming,LIANG Caitao,CAI Jianxin,LAI Weiyang,PAN Shuqiang,LIU Pingding,WEN Feng,MA Liji,CAI Qiuhan and WU Ge. Post-marketing revaluation of Compound Dingxiang Kaiwei Paste in treatment of functional abdominal pain with deficient cold of spleen and stomach syndrome in children[J]. Drugs & Clinic, 2018, 41(12): 2166-2170
Authors:GUO Hengchang  HU Siyuan  LI Xinmin  BAI Xiaohong  HAN Ziming  XU Huifu  LI Xueming  LIANG Caitao  CAI Jianxin  LAI Weiyang  PAN Shuqiang  LIU Pingding  WEN Feng  MA Liji  CAI Qiuhan  WU Ge
Affiliation:First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China,First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China,First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China,Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang 110032, China,The First Affiliated Hospital of Xinxiang Medical College, Xinxiang 453100, China,Wuhan Hospital Integrated Traditional Chinese and Western Medicine, Wuhan 430022, China,Handan Hospital of Traditional Chinese Medicine, Handan 056000, China,Shanxi Lu''an Mining(Group) Co., Ltd. General Hospital, Changzhi 046204, China,Wuhan hospital of Traditional Chinese Medicine, Wuhan 430014, China,Affiliated Hospital of Hebei Engineering University, Handan 056002, China,Maternal and Child Health Care Hospital of Qinzhou, Qinzhou 535000, China,Maternal and Child Health Care Hospital of Weinan, Weinan 714000, China,Changchun Children''s Hospital, Changchun 130061, China,Central Hospital of Zibo, Zibo 255000, China,First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China and First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China
Abstract:Objective To reevaluate the clinical efficacy and safety of Compound Dingxiang Kaiwei Paste in the treatment of syndrome of deficient cold of spleen and stomach in children with functional abdominal pain. Methods A random, double-blind, placebo parallel controll and multi-centered observational clinical approach were used. The tir al intended to include 240 paients, who were randomly divided into treatment group and control group according to 1:1 ratio. The treatment group was given Compound Dingxiang Kaiwei Paste and the control group with placebo for 2 weeks. Results A total of 239 patients were assigned to this study, and 230 of which entered full analysis set. Totally 217 patients were fitted in per-protocol set and 238 in safety set. The frequency of abdominal pain in the second week, the treatment group and the control group were 1.600 and 2.026 (covariance analysis, P=0.0070), respectively. Improvement rate of the intensity of abdominal pain in the second week were 80.00% and 67.83% (P=0.0355), respectively. And the effective rate of traditional Chinese medicine (TCM) syndromes were 86.09% and 59.13% (P=0.001), respectively. In this clinical trial, there were 9 cases (7.63%) of adverse events were reported in the treatment group and 10 cases (8.33%) in the control group (P>0.05). Four cases (3.39%) in the treatment group and 3 cases (2.50%) in the control group were judged by investigators as adverse reaction (P>0.05). Conclusion Compound Dingxiang Kaiwei Paste can reduce the frequency and the duration of abdominal pain and improve TCM syndromes functional abdominal pain with deficient cold of spleen and stomach syndrome in children, and the security is good.
Keywords:Compound Dingxiang Kaiwei Paste  children  functional abdominal pain  deficient cold of spleen and stomach syndrome  post-marketing reevaluation
点击此处可从《现代药物与临床》浏览原始摘要信息
点击此处可从《现代药物与临床》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号